Global pharma major Lupin Limited (Lupin) announced the launch of doxorubicin hydrochloride liposome injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials in the United States, ...

The first generic version of doxorubicin hydrochloride liposomal injection is now available in the United States. The generic product was approved by the US Food and Drug Administration (FDA ...

In February 2012, to address the shortage of doxorubicin hydrochloride liposome injection, the FDA announced it would exercise enforcement discretion for temporary controlled importation of ...

Dr. Reddy’s Doxorubicin Hydrochloride Liposome Injection is a sterile, translucent, red liposomal dispersion in 10-mL or 30-mL glass, single-dose vials. Each 10-mL vial contains 20 mg ...

Dr. Reddy’s Doxorubicin Hydrochloride Liposome Injection is a sterile, translucent, red liposomal dispersion in 10-mL or 30-mL glass, single-dose vials. Each 10-mL vial contains 20 mg ...

For instance, in 2020, Zydus Cadila received the U.S Food and Drug Administration’s approval to market Doxorubicin Hydrochloride Liposome injection (US RLD: Doxil Liposome Injection) in the ...

today announced the ANDA approval of DOXOrubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) from the United States Food and Drug Administration (US FDA).

A healthcare professional should administer doxorubicin hydrochloride liposome more slowly to prevent a person from having a reaction to it. Doctors may use doxorubicin alone or alongside other drugs.

Doxorubicin, also referred to as doxorubicin hydrochloride, is a chemotherapy drug. There’s currently no brand-name version of this drug. Doxorubicin is available as a liquid solution inside vials.

Hyderabad, May 17 (IANS) Pharma major Dr. Reddy’s Laboratories Ltd has received approval from the US Food and Drug Administration (USFDA) to launch doxorubicin hydrochloride liposome injection ...

has filed for registration of doxorubicin hydrochloride liposome injection for intravenous use, in the European markets. It is the therapeutic equivalent generic version of Janssen’s brand ...